Skip to main content
Mijn bibliotheek
Ga naar:
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
BSL Shop
Inloggen

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Erasmus MC heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

» Andere revante producten voor Erasmus MC studenten en medewerkers.

Registreer

Om ook buiten de locaties van Erasmus MC, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van Erasmus MC.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Journal of Autism and Developmental Disorders
Gepubliceerd in:

01-05-2013 | Original Paper

A Retrospective Study of Amitriptyline in Youth with Autism Spectrum Disorders

Auteurs: Irfan Bhatti, Andrew Thome, Patricia Oxler Smith, Galen Cook-Wiens, Hung Wen Yeh, Gary R. Gaffney, Jessica A. Hellings

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 5/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

We performed a retrospective chart review of 50 youths with Autism Spectrum Disorder (ASD), prescribed amitriptyline (AMI) for hyperactivity and impulsivity. Data was systematically extracted from 50 outpatient clinic charts, including AMI treatment duration, dose, trough levels and adverse events. Mean age was 9.4 years (4.6–17.9); 40 were males and 10 females. 30 % had failed atomoxetine and 40 % had failed ≥3 ADHD medications. Mean dose was 1.3 ± 0.6 mg/kg/day, mean trough level 114.1 ± 50.5 ng/ml, mean duration 3.4 years. Clinical Global Impressions Scale-Improvement (CGI-I) was ≤2 in 60 % of patients at the final visit, and in 82 % of patients for at least 50 % of follow-ups. Cautious use of low dose AMI shows promise for treatment-resistant youth with ASD accompanied by hyperactivity, impulsivity, aggression and self injury.
vorige artikel Using the Prevent-Teach-Reinforce Model with Families of Young Children with ASD
volgende artikel Development of T-STAT for Early Autism Screening
Literatuur
Akuffo, E., MacSweeney, D. A., & Gajwani, A. K. (1986). Multiple pathology in a mentally handicapped individual. BJP, 149, 377–378.CrossRef
Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485–491.PubMed
Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., et al. (1987). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, 28, 885–900.PubMedCrossRef
Arnold, L. (2006). Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1196–2005.PubMedCrossRef
American Medical Association. (1991). Clomipramine in the treatment of patients with obsessive-compulsive disorder. The clomipramine collaborative study group. Archives of General Psychiatry, 48, 730–738.
Biederman, J., & Jellinek, M. S. (1984). Psychopharmacology in children. New England Journal of Medicine, 310, 968–972.PubMedCrossRef
Campbell, M. (1988). Fenfluramine treatment of autism. Journal of Child Psychology and Psychiatry, 29, 1–10.PubMedCrossRef
Campbell, M., Anderson, L. T., Small, A. M., Locascio, J. J., Lynch, N. S., & Choroco, M. C. (1990). Naltrexone in autistic children: A double-blind and placebo-controlled study. Psychopharmacology Bulletin, 26, 130–135.PubMed
Chadwick, W., Mitchell, N., Caroll, J., Zhou, Y., Park, S. S., Wang, L., et al. (2011). Amitriptyline-mediated cognitive enhancement in aged 3 × tg Alzheimer’s disease mice is associated with neurogenesis and neurotrophic activity. PLoS ONE, 6, e21660.PubMedCrossRef
Cohen, I. L., Campbell, M., Posner, D., Small, A. M., Triebel, D., & Anderson, L. T. (1980). Behavioral effects of haloperidol in young autistic children: An objective analysis using a within-subjects reversal design. Journal of the American Academy of Child Psychiatry, 19, 665–677.PubMedCrossRef
Collier, R. (2009). Drug development cost estimates hard to swallow. CMAJ, 180, 279–280.PubMed
Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., & Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. Journal of American Medical Association, 302, 1765–1773.CrossRef
Davidson, J. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259–266.PubMedCrossRef
Dhillon, S., Hellings, J. A., & Butler, M. G. (2011). Genetics and mitochondrial abnormalities in autism spectrum disorders: A review. Current Genomics, 12, 322–332.PubMedCrossRef
Frye, R. E., & Rossignol, D. A. (2011). Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatric Research, 69, 41R–47R.PubMedCrossRef
Ganz, M. L. (2007). The lifetime distribution of the incremental societal costs of autism. Archives of Pediatrics and Adolescent Medicine, 161, 343–349.PubMedCrossRef
Geller, E., Ritvo, E. R., Freeman, B. J., & Yuwiler, A. (1982). Preliminary observations on the effect of fenfluramine on blood serotonin and symptoms in three autistic boys. New England Journal of Medicine, 307, 165–169.PubMedCrossRef
Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S. D., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441–447.PubMedCrossRef
Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology (MNIH Publication NO. 76–338). Washington, DC: US DHEW NIMH.
Hellings, J. A., Zarcone, J. R., Crandall, K., Wallace, D., & Schroeder, S. R. (2001). Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism. Journal of Child and Adolescent Psychopharmacology, 11, 229–238.PubMedCrossRef
Hellings, J. A., Zarcone, J. R., Valdovinos, M. G., Reese, R. M., Gaughan, E., & Schroeder, S. R. (2005). Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 15, 885–892.PubMedCrossRef
Hellings, J. A., Zarcone, J. R., Reese, R. M., Valdovinos, M. G., Marquis, J. G., Fleming, K. K., et al. (2006a). A crossover study of risperidone in children, adolescents and adults with mental retardation. Journal of Autism and Developmental Disorders, 36, 401–411.PubMedCrossRef
Hellings, J.A., Tanjim, S., Saranga, V., Thome, A. (2006a). Comorbidity and combination treatments with dextroamphetamine in youth with autism spectrum disorders (ASD) and attention deficit hyperactivity disorder (ADHD). [Poster] 50th Annual Meeting (NCDEU) Boca Raton, FL.
Hellings, J. A., Cardona, A., & Schroeder, S. R. (2010). Long-term safety and adverse events of risperidone in children, adolescents and adults with pervasive developmental disorders. Journal of Mental Health Research in Intellectual Disabilities, 3, 132–144.CrossRef
Hellings, J. A., Boehm, D., Yeh, H., & Schroeder, S. R. (2011). Long-term clinical aripiprazole efficacy and weight changes in youth with developmental disabilities including autism spectrum disorders. Journal of Mental Health Research in Intellectual Disabilities, 4, 1–14.CrossRef
Hellweg, R., Ziegenhorn, A., Heuser, I., & Deuschle, M. (2008). Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry, 41, 66–71.PubMedCrossRef
Horvath, K., & Perman, J. A. (2002). Autistic disorder and gastrointestinal disease. Current Opinion in Pediatrics, 14, 583–587.PubMedCrossRef
Jackson, J. (2010). Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ, 341, c5222.PubMedCrossRef
King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., et al. (2009). STAART psychopharmacology network: Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66, 583–590.PubMedCrossRef
Kuperman, S., Beeghly, J. H. L., Burns, T. L., & Tsai, L. Y. (1985). Serotonin relationships of autistic probands and their first-degree relatives. Journal of the American Academy of Child Psychiatry, 24, 186–190.PubMedCrossRef
Lecavalier, L., Leone, S., & Wiltz, J. (2006). The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders. Journal of Intellectual Disability Research, 50, 172–183.PubMedCrossRef
Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659–685.PubMedCrossRef
Marcus, R. N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., et al. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1110–1119.PubMedCrossRef
Max, M. (1987). Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology, 37, 589–596.PubMedCrossRef
Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., et al. (2009). Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124, 1533–1540.PubMedCrossRef
Perry, R., Campbell, M., Adams, P., Lynch, N., Spencer, E. K., Curren, E. L., et al. (1989). Long-term efficacy of haloperidol in autistic children: Continuous versus discontinuous drug administration. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 87–92.PubMedCrossRef
Posey, D. J., Wiegand, R. E., Wilkerson, J., Maynard, M., Stigler, K. A., & McDougle, C. J. (2006). Open-label atomoxetine for attention-deficit/hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 16, 599–610.PubMedCrossRef
Prince, J. B., Wilens, T. E., Biederman, J., Spencer, T. J., Millstein, R., Polisner, D. A., et al. (2000). A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 10, 193–204.PubMedCrossRef
Research Units in Pediatric Psychopharmacology (RUPP) Autism Network. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314–321.CrossRef
Research Units in Pediatric Psychopharmacology (RUPP) Autism Network. (2005). Randomized, controlled crossover trial of methylphenidate in pervasive development disorder with hyperactivity. Archives of General Psychiatry, 62, 1266–1327.CrossRef
Richelson, E., & Nelson, A. (1984). Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. JPET, 230, 94–102.
Rush, A. (2007). STAR*D: What have we learned? American Journal of Psychiatry, 02(164), 201.CrossRef
Sandman, C. A., Barron, J. L., & Colman, H. (1990). An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior. American Journal of Mental Retardation, 95, 93–102.PubMed
Stahl, S. M. (2008). Classical antidepressants, serotonin selective reuptake inhibitors and noradrenergic reuptake inhibitors. In Stahl’s essential psychopharmacology: Neuroscientific basis and practical application. Cambridge: Cambridge University Press.
Tamminga, C. A. (2011). When is polypharmacy an advantage? American Journal of Psychiatry, 168, 663.PubMedCrossRef
Wilens, T. E., Biederman, J., Prince, J., Spencer, T. J., Faraone, S. V., Warburton, R., et al. (1996). Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. American Journal of Psychiatry, 153, 1147–1153.PubMed
Zarcone, J. R., Lindauer, S. E., Morse, P. S., Crosland, K. A., Valdovinos, M. G., McKerchar, T. L., et al. (2004). Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis. American Journal of Mental Retardation, 109, 310–321.PubMedCrossRef
Metagegevens
Titel
A Retrospective Study of Amitriptyline in Youth with Autism Spectrum Disorders
Auteurs
Irfan Bhatti
Andrew Thome
Patricia Oxler Smith
Galen Cook-Wiens
Hung Wen Yeh
Gary R. Gaffney
Jessica A. Hellings
Publicatiedatum
01-05-2013
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 5/2013
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-012-1647-0

Andere artikelen Uitgave 5/2013

Brief Report: Comparability of DSM-IV and DSM-5 ASD Research Samples

  • Brief Report

Using the Prevent-Teach-Reinforce Model with Families of Young Children with ASD

  • Original paper

Preschool Based JASPER Intervention in Minimally Verbal Children with Autism: Pilot RCT

  • Brief Report

Excess Mortality and Causes of Death in Autism Spectrum Disorders: A Follow up of the 1980s Utah/UCLA Autism Epidemiologic Study

The French Version of the Autism-Spectrum Quotient in Adolescents: A Cross-Cultural Validation Study

From Action to Interaction: Exploring the Contribution of Body Motion Cues to Social Understanding in Typical Development and in Autism Spectrum Disorders

  • Original Paper